| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 100.9 | 134.0 | 0.0 |
| Other income | 0.1 | 0.1 | 0.0 |
| Total income | 101.1 | 134.1 | 0.0 |
| Profit before exceptional items & tax | 10.4 | 8.3 | 0.0 |
| Profit before tax | 10.4 | 8.3 | 0.0 |
| Net profit | 9.4 | 7.7 | 0.0 |
| Operating margin | 10.3% | 6.2% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | +22.10% |
|---|---|
| Operating profit, quarter on quarter | +25.60% |
BSE results filing, NSE: MACINTR. Figures extracted from the filing.
Astal Laboratories Ltd: key numbers
- Share price
- ₹71.62
- Market cap
- ₹302.4 Cr
- Revenue (annual)
- ₹156.0 Cr
- Net profit (annual)
- ₹8.12 Cr
- P/E (TTM)
- 31.1×Sector 41.4×
- Promoter holding
- 4.53%-0.17% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Astal Laboratories Ltd
All →Astal Laboratories Promoter Buying: ₹0.2 Cr
Promoter Aceso Research Labs LLP acquired 25,417 equity shares of Astal Laboratories Ltd via market purchase, increasing their stake from 4.53% to 4.59%.
- Value
- ₹0.20 Cr
- Promoter stake change
- +0.06%
Astal Laboratories Promoter Buying
Astal Laboratories' promoter ACESO Research Labs LLP bought equity shares on BSE under a SEBI PIT disclosure. The open-market purchase signals promoter confidence.
Astal Laboratories Annual Report
Astal Laboratories has submitted its Annual Report for the financial year 2025-26 and the notice for its 33rd Annual General Meeting scheduled for September 29, 2026.
Astal Laboratories Annual General Meeting
Astal Laboratories will hold its 33rd Annual General Meeting on September 29, 2026. The company also announced book closure and e-voting dates.
Astal Laboratories Other Announcement
Astal Laboratories Limited appointed Avnesh Jain & Co. as Cost Auditors for the financial year 2026-27.
Astal Laboratories Board Meeting Outcome
Astal Laboratories approved its Board Report, appointed Cost Auditors, and scheduled its 33rd Annual General Meeting for September 29, 2026, alongside related administrative matters.